Pharma & Healthcare
Thyrogen and Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 660558
- Pages: 87
- Figures: 190
- Views: 6
THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a genetically modified Chinese hamster ovary cell line.
The global market for Thyrogen and Biosimilar was estimated to be worth US$ 257 million in 2023 and is forecast to a readjusted size of US$ 682.6 million by 2030 with a CAGR of 15.7% during the forecast period 2024-2030
North American market for Thyrogen and Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Thyrogen and Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Thyrogen and Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Thyrogen and Biosimilar include Sanofi and Sato Pharmaceutical etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Thyrogen and Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thyrogen and Biosimilar by region & country, by Type, and by Application.
The Thyrogen and Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyrogen and Biosimilar.
Market Segmentation
By Company
Sanofi
Sato Pharmaceutical
Segment by Type:
Brand
Biosimilar
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Thyrogen and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Thyrogen and Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Thyrogen and Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Thyrogen and Biosimilar was estimated to be worth US$ 257 million in 2023 and is forecast to a readjusted size of US$ 682.6 million by 2030 with a CAGR of 15.7% during the forecast period 2024-2030
North American market for Thyrogen and Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Thyrogen and Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Thyrogen and Biosimilar was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Thyrogen and Biosimilar include Sanofi and Sato Pharmaceutical etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Thyrogen and Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thyrogen and Biosimilar by region & country, by Type, and by Application.
The Thyrogen and Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyrogen and Biosimilar.
Market Segmentation
By Company
Sanofi
Sato Pharmaceutical
Segment by Type:
Brand
Biosimilar
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Thyrogen and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Thyrogen and Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Thyrogen and Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Thyrogen and Biosimilar Product Introduction
1.2 Global Thyrogen and Biosimilar Market Size Forecast
1.2.1 Global Thyrogen and Biosimilar Sales Value (2019-2030)
1.2.2 Global Thyrogen and Biosimilar Sales Volume (2019-2030)
1.2.3 Global Thyrogen and Biosimilar Sales Price (2019-2030)
1.3 Thyrogen and Biosimilar Market Trends & Drivers
1.3.1 Thyrogen and Biosimilar Industry Trends
1.3.2 Thyrogen and Biosimilar Market Drivers & Opportunity
1.3.3 Thyrogen and Biosimilar Market Challenges
1.3.4 Thyrogen and Biosimilar Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Thyrogen and Biosimilar Players Revenue Ranking (2023)
2.2 Global Thyrogen and Biosimilar Revenue by Company (2019-2024)
2.3 Global Thyrogen and Biosimilar Players Sales Volume Ranking (2023)
2.4 Global Thyrogen and Biosimilar Sales Volume by Company Players (2019-2024)
2.5 Global Thyrogen and Biosimilar Average Price by Company (2019-2024)
2.6 Key Manufacturers Thyrogen and Biosimilar Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Thyrogen and Biosimilar Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Thyrogen and Biosimilar
2.9 Thyrogen and Biosimilar Market Competitive Analysis
2.9.1 Thyrogen and Biosimilar Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Thyrogen and Biosimilar Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyrogen and Biosimilar as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Brand
3.1.2 Biosimilar
3.2 Global Thyrogen and Biosimilar Sales Value by Type
3.2.1 Global Thyrogen and Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Thyrogen and Biosimilar Sales Value, by Type (2019-2030)
3.2.3 Global Thyrogen and Biosimilar Sales Value, by Type (%) (2019-2030)
3.3 Global Thyrogen and Biosimilar Sales Volume by Type
3.3.1 Global Thyrogen and Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Thyrogen and Biosimilar Sales Volume, by Type (2019-2030)
3.3.3 Global Thyrogen and Biosimilar Sales Volume, by Type (%) (2019-2030)
3.4 Global Thyrogen and Biosimilar Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Thyrogen and Biosimilar Sales Value by Application
4.2.1 Global Thyrogen and Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Thyrogen and Biosimilar Sales Value, by Application (2019-2030)
4.2.3 Global Thyrogen and Biosimilar Sales Value, by Application (%) (2019-2030)
4.3 Global Thyrogen and Biosimilar Sales Volume by Application
4.3.1 Global Thyrogen and Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Thyrogen and Biosimilar Sales Volume, by Application (2019-2030)
4.3.3 Global Thyrogen and Biosimilar Sales Volume, by Application (%) (2019-2030)
4.4 Global Thyrogen and Biosimilar Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Thyrogen and Biosimilar Sales Value by Region
5.1.1 Global Thyrogen and Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Thyrogen and Biosimilar Sales Value by Region (2019-2024)
5.1.3 Global Thyrogen and Biosimilar Sales Value by Region (2025-2030)
5.1.4 Global Thyrogen and Biosimilar Sales Value by Region (%), (2019-2030)
5.2 Global Thyrogen and Biosimilar Sales Volume by Region
5.2.1 Global Thyrogen and Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Thyrogen and Biosimilar Sales Volume by Region (2019-2024)
5.2.3 Global Thyrogen and Biosimilar Sales Volume by Region (2025-2030)
5.2.4 Global Thyrogen and Biosimilar Sales Volume by Region (%), (2019-2030)
5.3 Global Thyrogen and Biosimilar Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Thyrogen and Biosimilar Sales Value, 2019-2030
5.4.2 North America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Thyrogen and Biosimilar Sales Value, 2019-2030
5.5.2 Europe Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Thyrogen and Biosimilar Sales Value, 2019-2030
5.6.2 Asia Pacific Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Thyrogen and Biosimilar Sales Value, 2019-2030
5.7.2 South America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Thyrogen and Biosimilar Sales Value, 2019-2030
5.8.2 Middle East & Africa Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Thyrogen and Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Thyrogen and Biosimilar Sales Value
6.2.1 Key Countries/Regions Thyrogen and Biosimilar Sales Value, 2019-2030
6.2.2 Key Countries/Regions Thyrogen and Biosimilar Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Thyrogen and Biosimilar Sales Value, 2019-2030
6.3.2 United States Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Thyrogen and Biosimilar Sales Value, 2019-2030
6.4.2 Europe Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Thyrogen and Biosimilar Sales Value, 2019-2030
6.5.2 China Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.5.3 China Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Thyrogen and Biosimilar Sales Value, 2019-2030
6.6.2 Japan Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Thyrogen and Biosimilar Sales Value, 2019-2030
6.7.2 South Korea Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Thyrogen and Biosimilar Sales Value, 2019-2030
6.8.2 Southeast Asia Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Thyrogen and Biosimilar Sales Value, 2019-2030
6.9.2 India Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.9.3 India Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Thyrogen and Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Thyrogen and Biosimilar Product Offerings
7.1.5 Sanofi Recent Development
7.2 Sato Pharmaceutical
7.2.1 Sato Pharmaceutical Company Information
7.2.2 Sato Pharmaceutical Introduction and Business Overview
7.2.3 Sato Pharmaceutical Thyrogen and Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sato Pharmaceutical Thyrogen and Biosimilar Product Offerings
7.2.5 Sato Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Thyrogen and Biosimilar Industrial Chain
8.2 Thyrogen and Biosimilar Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Thyrogen and Biosimilar Sales Model
8.5.2 Sales Channel
8.5.3 Thyrogen and Biosimilar Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Thyrogen and Biosimilar Product Introduction
1.2 Global Thyrogen and Biosimilar Market Size Forecast
1.2.1 Global Thyrogen and Biosimilar Sales Value (2019-2030)
1.2.2 Global Thyrogen and Biosimilar Sales Volume (2019-2030)
1.2.3 Global Thyrogen and Biosimilar Sales Price (2019-2030)
1.3 Thyrogen and Biosimilar Market Trends & Drivers
1.3.1 Thyrogen and Biosimilar Industry Trends
1.3.2 Thyrogen and Biosimilar Market Drivers & Opportunity
1.3.3 Thyrogen and Biosimilar Market Challenges
1.3.4 Thyrogen and Biosimilar Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Thyrogen and Biosimilar Players Revenue Ranking (2023)
2.2 Global Thyrogen and Biosimilar Revenue by Company (2019-2024)
2.3 Global Thyrogen and Biosimilar Players Sales Volume Ranking (2023)
2.4 Global Thyrogen and Biosimilar Sales Volume by Company Players (2019-2024)
2.5 Global Thyrogen and Biosimilar Average Price by Company (2019-2024)
2.6 Key Manufacturers Thyrogen and Biosimilar Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Thyrogen and Biosimilar Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Thyrogen and Biosimilar
2.9 Thyrogen and Biosimilar Market Competitive Analysis
2.9.1 Thyrogen and Biosimilar Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Thyrogen and Biosimilar Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyrogen and Biosimilar as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Brand
3.1.2 Biosimilar
3.2 Global Thyrogen and Biosimilar Sales Value by Type
3.2.1 Global Thyrogen and Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Thyrogen and Biosimilar Sales Value, by Type (2019-2030)
3.2.3 Global Thyrogen and Biosimilar Sales Value, by Type (%) (2019-2030)
3.3 Global Thyrogen and Biosimilar Sales Volume by Type
3.3.1 Global Thyrogen and Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Thyrogen and Biosimilar Sales Volume, by Type (2019-2030)
3.3.3 Global Thyrogen and Biosimilar Sales Volume, by Type (%) (2019-2030)
3.4 Global Thyrogen and Biosimilar Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Thyrogen and Biosimilar Sales Value by Application
4.2.1 Global Thyrogen and Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Thyrogen and Biosimilar Sales Value, by Application (2019-2030)
4.2.3 Global Thyrogen and Biosimilar Sales Value, by Application (%) (2019-2030)
4.3 Global Thyrogen and Biosimilar Sales Volume by Application
4.3.1 Global Thyrogen and Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Thyrogen and Biosimilar Sales Volume, by Application (2019-2030)
4.3.3 Global Thyrogen and Biosimilar Sales Volume, by Application (%) (2019-2030)
4.4 Global Thyrogen and Biosimilar Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Thyrogen and Biosimilar Sales Value by Region
5.1.1 Global Thyrogen and Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Thyrogen and Biosimilar Sales Value by Region (2019-2024)
5.1.3 Global Thyrogen and Biosimilar Sales Value by Region (2025-2030)
5.1.4 Global Thyrogen and Biosimilar Sales Value by Region (%), (2019-2030)
5.2 Global Thyrogen and Biosimilar Sales Volume by Region
5.2.1 Global Thyrogen and Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Thyrogen and Biosimilar Sales Volume by Region (2019-2024)
5.2.3 Global Thyrogen and Biosimilar Sales Volume by Region (2025-2030)
5.2.4 Global Thyrogen and Biosimilar Sales Volume by Region (%), (2019-2030)
5.3 Global Thyrogen and Biosimilar Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Thyrogen and Biosimilar Sales Value, 2019-2030
5.4.2 North America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Thyrogen and Biosimilar Sales Value, 2019-2030
5.5.2 Europe Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Thyrogen and Biosimilar Sales Value, 2019-2030
5.6.2 Asia Pacific Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Thyrogen and Biosimilar Sales Value, 2019-2030
5.7.2 South America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Thyrogen and Biosimilar Sales Value, 2019-2030
5.8.2 Middle East & Africa Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Thyrogen and Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Thyrogen and Biosimilar Sales Value
6.2.1 Key Countries/Regions Thyrogen and Biosimilar Sales Value, 2019-2030
6.2.2 Key Countries/Regions Thyrogen and Biosimilar Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Thyrogen and Biosimilar Sales Value, 2019-2030
6.3.2 United States Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Thyrogen and Biosimilar Sales Value, 2019-2030
6.4.2 Europe Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Thyrogen and Biosimilar Sales Value, 2019-2030
6.5.2 China Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.5.3 China Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Thyrogen and Biosimilar Sales Value, 2019-2030
6.6.2 Japan Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Thyrogen and Biosimilar Sales Value, 2019-2030
6.7.2 South Korea Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Thyrogen and Biosimilar Sales Value, 2019-2030
6.8.2 Southeast Asia Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Thyrogen and Biosimilar Sales Value, 2019-2030
6.9.2 India Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
6.9.3 India Thyrogen and Biosimilar Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Thyrogen and Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Thyrogen and Biosimilar Product Offerings
7.1.5 Sanofi Recent Development
7.2 Sato Pharmaceutical
7.2.1 Sato Pharmaceutical Company Information
7.2.2 Sato Pharmaceutical Introduction and Business Overview
7.2.3 Sato Pharmaceutical Thyrogen and Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sato Pharmaceutical Thyrogen and Biosimilar Product Offerings
7.2.5 Sato Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Thyrogen and Biosimilar Industrial Chain
8.2 Thyrogen and Biosimilar Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Thyrogen and Biosimilar Sales Model
8.5.2 Sales Channel
8.5.3 Thyrogen and Biosimilar Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Thyrogen and Biosimilar Market Trends
Table 2. Thyrogen and Biosimilar Market Drivers & Opportunity
Table 3. Thyrogen and Biosimilar Market Challenges
Table 4. Thyrogen and Biosimilar Market Restraints
Table 5. Global Thyrogen and Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Thyrogen and Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Thyrogen and Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Thyrogen and Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Thyrogen and Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Thyrogen and Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Thyrogen and Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Thyrogen and Biosimilar
Table 13. Global Thyrogen and Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyrogen and Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Thyrogen and Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Thyrogen and Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Thyrogen and Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Thyrogen and Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Thyrogen and Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Thyrogen and Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Thyrogen and Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Thyrogen and Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Thyrogen and Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Thyrogen and Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Thyrogen and Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Thyrogen and Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Thyrogen and Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Thyrogen and Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Thyrogen and Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Thyrogen and Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Thyrogen and Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Thyrogen and Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Thyrogen and Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Thyrogen and Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Thyrogen and Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Thyrogen and Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Thyrogen and Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Thyrogen and Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Thyrogen and Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Thyrogen and Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Thyrogen and Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Thyrogen and Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Thyrogen and Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Thyrogen and Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Thyrogen and Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Thyrogen and Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Thyrogen and Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Thyrogen and Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Thyrogen and Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Thyrogen and Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Thyrogen and Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Thyrogen and Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Thyrogen and Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Thyrogen and Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Thyrogen and Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Sanofi Company Information
Table 58. Sanofi Introduction and Business Overview
Table 59. Sanofi Thyrogen and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Sanofi Thyrogen and Biosimilar Product Offerings
Table 61. Sanofi Recent Development
Table 62. Sato Pharmaceutical Company Information
Table 63. Sato Pharmaceutical Introduction and Business Overview
Table 64. Sato Pharmaceutical Thyrogen and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Sato Pharmaceutical Thyrogen and Biosimilar Product Offerings
Table 66. Sato Pharmaceutical Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Thyrogen and Biosimilar Downstream Customers
Table 70. Thyrogen and Biosimilar Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Thyrogen and Biosimilar Product Picture
Figure 2. Global Thyrogen and Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Thyrogen and Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Thyrogen and Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Thyrogen and Biosimilar Report Years Considered
Figure 7. Global Thyrogen and Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Thyrogen and Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Thyrogen and Biosimilar Revenue in 2023
Figure 10. Thyrogen and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Brand Picture
Figure 12. Biosimilar Picture
Figure 13. Global Thyrogen and Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Thyrogen and Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Thyrogen and Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Thyrogen and Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Thyrogen and Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Pharmacy
Figure 20. Product Picture of Other
Figure 21. Global Thyrogen and Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Thyrogen and Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Thyrogen and Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Thyrogen and Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Thyrogen and Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Thyrogen and Biosimilar Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Thyrogen and Biosimilar Sales Volume (%), (2019-2030)
Figure 38. United States Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 44. China Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 46. China Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 56. India Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 58. India Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 59. Thyrogen and Biosimilar Industrial Chain
Figure 60. Thyrogen and Biosimilar Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Thyrogen and Biosimilar Market Trends
Table 2. Thyrogen and Biosimilar Market Drivers & Opportunity
Table 3. Thyrogen and Biosimilar Market Challenges
Table 4. Thyrogen and Biosimilar Market Restraints
Table 5. Global Thyrogen and Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Thyrogen and Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Thyrogen and Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Thyrogen and Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Thyrogen and Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Thyrogen and Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Thyrogen and Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Thyrogen and Biosimilar
Table 13. Global Thyrogen and Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyrogen and Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Thyrogen and Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Thyrogen and Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Thyrogen and Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Thyrogen and Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Thyrogen and Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Thyrogen and Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Thyrogen and Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Thyrogen and Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Thyrogen and Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Thyrogen and Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Thyrogen and Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Thyrogen and Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Thyrogen and Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Thyrogen and Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Thyrogen and Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Thyrogen and Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Thyrogen and Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Thyrogen and Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Thyrogen and Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Thyrogen and Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Thyrogen and Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Thyrogen and Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Thyrogen and Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Thyrogen and Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Thyrogen and Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Thyrogen and Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Thyrogen and Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Thyrogen and Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Thyrogen and Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Thyrogen and Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Thyrogen and Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Thyrogen and Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Thyrogen and Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Thyrogen and Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Thyrogen and Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Thyrogen and Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Thyrogen and Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Thyrogen and Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Thyrogen and Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Thyrogen and Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Thyrogen and Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Sanofi Company Information
Table 58. Sanofi Introduction and Business Overview
Table 59. Sanofi Thyrogen and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Sanofi Thyrogen and Biosimilar Product Offerings
Table 61. Sanofi Recent Development
Table 62. Sato Pharmaceutical Company Information
Table 63. Sato Pharmaceutical Introduction and Business Overview
Table 64. Sato Pharmaceutical Thyrogen and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Sato Pharmaceutical Thyrogen and Biosimilar Product Offerings
Table 66. Sato Pharmaceutical Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Thyrogen and Biosimilar Downstream Customers
Table 70. Thyrogen and Biosimilar Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Thyrogen and Biosimilar Product Picture
Figure 2. Global Thyrogen and Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Thyrogen and Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Thyrogen and Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Thyrogen and Biosimilar Report Years Considered
Figure 7. Global Thyrogen and Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Thyrogen and Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Thyrogen and Biosimilar Revenue in 2023
Figure 10. Thyrogen and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Brand Picture
Figure 12. Biosimilar Picture
Figure 13. Global Thyrogen and Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Thyrogen and Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Thyrogen and Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Thyrogen and Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Thyrogen and Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Pharmacy
Figure 20. Product Picture of Other
Figure 21. Global Thyrogen and Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Thyrogen and Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Thyrogen and Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Thyrogen and Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Thyrogen and Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Thyrogen and Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Thyrogen and Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Thyrogen and Biosimilar Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Thyrogen and Biosimilar Sales Volume (%), (2019-2030)
Figure 38. United States Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 44. China Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 46. China Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 56. India Thyrogen and Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Thyrogen and Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 58. India Thyrogen and Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 59. Thyrogen and Biosimilar Industrial Chain
Figure 60. Thyrogen and Biosimilar Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232